Estuary Biotherapeutics

Trestle Biotherapeutics

This company develops implantable bioengineered kidney tissues to restore renal function for patients suffering from end-stage renal disease.

Mironid

This biopharmaceutical company develops small molecule therapeutics to treat autosomal dominant polycystic kidney disease and other rare hereditary kidney conditions.

Purespring Therapeutics

This company develops gene therapies for patients with chronic renal diseases to preserve kidney function and treat conditions like IgA nephropathy.

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

Helex

This biotechnology company develops gene editing therapeutics and lipid nanoparticle delivery platforms for patients suffering from genetic kidney diseases.

Nephrogen

This biotechnology company develops artificial intelligence-driven gene therapies to treat kidney and pancreatic diseases for patients with genetic conditions.

River Renal

This clinical-stage biotechnology company develops novel pharmaceutical therapies targeting orphan renal diseases for patients with unmet medical needs.

Purespring

Purespring develops gene therapies targeting podocyte cells to treat chronic kidney diseases for patients with conditions such as IgA nephropathy and Alport syndrome.